Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial

Journal:

Nature Communications

Published:

2026-01-06

DOI:

10.1038/s41467-025-68112-6

Affiliations:

12

Authors:

26

Go to article

Institutions	Authors	Share
Dushu Lake Hospital, China	15.500000 15.500000	0.60
The First Affiliated Hospital of Soochow University, China	2.500000	0.10
T-MAXIMUM Biotech, China	2.000000	0.08
National Research Institute for Family Planning, China	1.500000	0.06
National Human Genetic Resources Center, China	1.500000	0.06
Ruijin Hospital, SJTU, China	1.000000	0.04
Suzhou Wuzhong People’s Hospital, China	1.000000	0.04
Army Medical University, China	1.000000	0.04

Interested in Oncology and Carcinogenesis?